Restless legs syndrome: Nonpharmacologic and pharmacologic treatments

John W. Winkelman, Richard P. Allen, Penny Tenzer, Wayne Hening

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Treatment of restless legs syndrome (RLS) has as its goals alleviation of the primary symptoms of the disorder and establishment of normal sleep. Dopamine agonists are considered first-line treatment when daily treatment for primary RLS is indicated. Gabapentin and opioids may be of value for refractory cases. Initial treatment of secondary RLS should address the underlying cause.

Original languageEnglish
Pages (from-to)13-16
Number of pages4
JournalGeriatrics
Volume62
Issue number10
StatePublished - Oct 1 2007
Externally publishedYes

Fingerprint

Restless Legs Syndrome
Dopamine Agonists
Therapeutics
Opioid Analgesics
Sleep

Keywords

  • Anticonvulsants
  • Dopamine agonists
  • Iron supplementation
  • Opioids
  • Restless legs syndrome
  • Sedatives
  • Sleep deprivation

ASJC Scopus subject areas

  • Geriatrics and Gerontology

Cite this

Winkelman, J. W., Allen, R. P., Tenzer, P., & Hening, W. (2007). Restless legs syndrome: Nonpharmacologic and pharmacologic treatments. Geriatrics, 62(10), 13-16.

Restless legs syndrome : Nonpharmacologic and pharmacologic treatments. / Winkelman, John W.; Allen, Richard P.; Tenzer, Penny; Hening, Wayne.

In: Geriatrics, Vol. 62, No. 10, 01.10.2007, p. 13-16.

Research output: Contribution to journalArticle

Winkelman, JW, Allen, RP, Tenzer, P & Hening, W 2007, 'Restless legs syndrome: Nonpharmacologic and pharmacologic treatments', Geriatrics, vol. 62, no. 10, pp. 13-16.
Winkelman JW, Allen RP, Tenzer P, Hening W. Restless legs syndrome: Nonpharmacologic and pharmacologic treatments. Geriatrics. 2007 Oct 1;62(10):13-16.
Winkelman, John W. ; Allen, Richard P. ; Tenzer, Penny ; Hening, Wayne. / Restless legs syndrome : Nonpharmacologic and pharmacologic treatments. In: Geriatrics. 2007 ; Vol. 62, No. 10. pp. 13-16.
@article{bf0b44a1501642d9a03f45465e3c1fe9,
title = "Restless legs syndrome: Nonpharmacologic and pharmacologic treatments",
abstract = "Treatment of restless legs syndrome (RLS) has as its goals alleviation of the primary symptoms of the disorder and establishment of normal sleep. Dopamine agonists are considered first-line treatment when daily treatment for primary RLS is indicated. Gabapentin and opioids may be of value for refractory cases. Initial treatment of secondary RLS should address the underlying cause.",
keywords = "Anticonvulsants, Dopamine agonists, Iron supplementation, Opioids, Restless legs syndrome, Sedatives, Sleep deprivation",
author = "Winkelman, {John W.} and Allen, {Richard P.} and Penny Tenzer and Wayne Hening",
year = "2007",
month = "10",
day = "1",
language = "English",
volume = "62",
pages = "13--16",
journal = "Geriatrics",
issn = "0016-867X",
publisher = "Advanstar Communications",
number = "10",

}

TY - JOUR

T1 - Restless legs syndrome

T2 - Nonpharmacologic and pharmacologic treatments

AU - Winkelman, John W.

AU - Allen, Richard P.

AU - Tenzer, Penny

AU - Hening, Wayne

PY - 2007/10/1

Y1 - 2007/10/1

N2 - Treatment of restless legs syndrome (RLS) has as its goals alleviation of the primary symptoms of the disorder and establishment of normal sleep. Dopamine agonists are considered first-line treatment when daily treatment for primary RLS is indicated. Gabapentin and opioids may be of value for refractory cases. Initial treatment of secondary RLS should address the underlying cause.

AB - Treatment of restless legs syndrome (RLS) has as its goals alleviation of the primary symptoms of the disorder and establishment of normal sleep. Dopamine agonists are considered first-line treatment when daily treatment for primary RLS is indicated. Gabapentin and opioids may be of value for refractory cases. Initial treatment of secondary RLS should address the underlying cause.

KW - Anticonvulsants

KW - Dopamine agonists

KW - Iron supplementation

KW - Opioids

KW - Restless legs syndrome

KW - Sedatives

KW - Sleep deprivation

UR - http://www.scopus.com/inward/record.url?scp=35349029765&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35349029765&partnerID=8YFLogxK

M3 - Article

C2 - 17922563

AN - SCOPUS:35349029765

VL - 62

SP - 13

EP - 16

JO - Geriatrics

JF - Geriatrics

SN - 0016-867X

IS - 10

ER -